Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)

The mTOQ‑4 is a brief four‑item patient questionnaire that screens how effectively acute migraine treatments relieve pain and restore function.

After taking your migraine medication, are you pain-free within 2 hours for most attacks?
Never or rarely0Less than half the time+1Half the time or greater+2
Does 1 dose of your migraine medication usually relieve your headache and keep it away for at least 24 hours?
Never or rarely0Less than half the time+1Half of the time or greater+2
Are you comfortable enough with your migraine medication to be able to plan your daily activities?
Never or rarely0Less than half the time+1Half the time or greater+2
After taking your migraine medication, do you feel in control of your migraines enough so that you feel you can return to normal function?
Never or rarely0Less than half the time+1Half the time or greater+2

Indications for Use

Used to assess adequacy of acute migraine treatment in adults with episodic or chronic migraine and to identify suboptimal response requiring regimen change. Provides a validated, patient‑reported measure of treatment optimization; psychometric validation in >8600 patients showed strong performance in both episodic and chronic migraine (AMPP study 1 [Level III evidence]). Higher scores correlate with lower disability and better quality of life (OVERCOME cohort 2 [Level III evidence]).

Insights & Cautions

Indicates how well acute therapy restores function and relief; higher scores reflect good optimization and correlate with lower disability and better HRQoL in large observational data 1 [Level II evidence].
Useful for quickly flagging suboptimal treatment but not a diagnostic tool and not validated to guide specific drug choices.
Cautions: patient‑reported recall bias, limited sensitivity to attack‑level variability, and not designed to compare medication classes.